{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:24:48Z","timestamp":1793215488086,"version":"4.5.0"},"reference-count":73,"publisher":"Georg Thieme Verlag KG","issue":"02","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Respir Crit Care Med"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Community-acquired pneumonia (CAP) is globally one of the major causes of hospitalization and mortality. Severe CAP (sCAP) presents great challenges and need a comprehensive understanding of its long-term outcomes. Cardiovascular events and neurological impairment, due to persistent inflammation and hypoxemia, contribute to long-term outcomes in CAP, including mortality. Very few data are available in the specific population of sCAP. Multiple studies have reported variable 1-year mortality rates for patients with CAP up to 40.7%, with a clear influence by age, comorbidities, and disease severity. In terms of treatment, the potential protective role of macrolides in reducing mortality emphasizes the importance of appropriate empiric antibiotic therapy. This narrative review explores the growing interest in the literature focusing on the long-term implications of sCAP. Improved understanding of long-term outcomes in sCAP can facilitate targeted interventions and enhance posthospitalization care protocols.<\/jats:p>","DOI":"10.1055\/s-0044-1781426","type":"journal-article","created":{"date-parts":[[2024,2,23]],"date-time":"2024-02-23T23:58:30Z","timestamp":1708732710000},"page":"266-273","source":"Crossref","is-referenced-by-count":9,"title":["Long-Term Outcomes in Severe Community-Acquired Pneumonia"],"prefix":"10.1055","volume":"45","author":[{"given":"Francesco","family":"Carella","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Milan, Italy"},{"name":"Respiratory Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0090-4531","authenticated-orcid":false,"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Milan, Italy"},{"name":"Respiratory Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Stainer","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Milan, Italy"},{"name":"Respiratory Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Voza","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Milan, Italy"},{"name":"Emergency Medicine, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[{"name":"Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS C\u00e0 Granda Ospedale Maggiore Policlinico, Milan, Italy"},{"name":"Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2024,2,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(21)00630-9","article-title":"Community-acquired pneumonia","volume":"398","author":"S Aliberti","year":"2021","journal-title":"Lancet"},{"issue":"06","key":"ref2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"49","author":"I Martin-Loeches","year":"2023","journal-title":"Intensive Care Med"},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1093\/cid\/cix647","article-title":"Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality","volume":"65","author":"J A Ramirez","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"06","key":"ref4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1055\/s-0036-1593754","article-title":"Complication of community-acquired pneumonia (including cardiac complications)","volume":"37","author":"M I Restrepo","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"e0192750","DOI":"10.1371\/journal.pone.0192750","article-title":"Predicting 1-year mortality after hospitalization for community-acquired pneumonia","volume":"13","author":"A Uranga","year":"2018","journal-title":"PLoS One"},{"issue":"17","key":"ref6","first-page":"30156","article-title":"Prognosis of hospitalized patients with community-acquired pneumonia","volume":"17","author":"F Tokgoz Akyil","year":"2018","journal-title":"Pulmonology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"107663","DOI":"10.1016\/j.pharmthera.2020.107663","article-title":"Updates on community acquired pneumonia management in the ICU","volume":"217","author":"G B Nair","year":"2021","journal-title":"Pharmacol Ther"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1465-9921-15-27","article-title":"Phenotyping community-acquired pneumonia according to the presence of acute respiratory failure and severe sepsis","volume":"15","author":"S Aliberti","year":"2014","journal-title":"Respir Res"},{"issue":"S 02","key":"ref9","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"L A Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00134-019-05519-y","article-title":"Challenges in severe community-acquired pneumonia: a point-of-view review","volume":"45","author":"A Torres","year":"2019","journal-title":"Intensive Care Med"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1086\/589754","article-title":"SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia","volume":"47","author":"P GP Charles","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4104\/pcrj.2013.00011","article-title":"Comparison of severity predictive rules for hospitalised nursing home-acquired pneumonia in Korea: a retrospective observational study","volume":"22","author":"J C Lee","year":"2013","journal-title":"Prim Care Respir J"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1164\/rccm.200602-177OC","article-title":"Development and validation of a clinical prediction rule for severe community-acquired pneumonia","volume":"174","author":"P P Espa\u00f1a","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"09","key":"ref14","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1093\/cid\/ciy723","article-title":"Prevalence and etiology of community-acquired pneumonia in immunocompromised patients","volume":"68","author":"M F Di Pasquale","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"06","key":"ref15","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00001432-200112000-00007","article-title":"Severe community-acquired pneumonia: current outcomes, epidemiology, etiology, and therapy","volume":"14","author":"M I Restrepo","year":"2001","journal-title":"Curr Opin Infect Dis"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.2102084","article-title":"Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria","volume":"166","author":"D C Angus","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02425150","article-title":"A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit","volume":"21","author":"O Leroy","year":"1995","journal-title":"Intensive Care Med"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0954-6111(06)80141-1","article-title":"The aetiology, management and outcome of severe community-acquired pneumonia on the intensive care unit","volume":"86","author":"The British Thoracic Society Research Committee and The Public Health Laboratory Service","year":"1992","journal-title":"Respir Med"},{"issue":"04","key":"ref19","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1017\/S0950268815001971","article-title":"Long-term mortality of hospitalized pneumonia in the EPIC-Norfolk cohort","volume":"144","author":"P K Myint","year":"2016","journal-title":"Epidemiol Infect"},{"issue":"12","key":"ref20","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.3855\/jidc.14881","article-title":"Predictors of long-term outcomes in the older adults with community-acquired pneumonia","volume":"15","author":"S Surme","year":"2021","journal-title":"J Infect Dev Ctries"},{"issue":"06","key":"ref21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/MD.0b013e318190f444","article-title":"Long-term morbidity and mortality after hospitalization with community-acquired pneumonia: a population-based cohort study","volume":"87","author":"J Johnstone","year":"2008","journal-title":"Medicine (Baltimore)"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12879-014-0730-x","article-title":"Pneumonia severity, comorbidity and 1-year mortality in predominantly older adults with community-acquired pneumonia: a cohort study","volume":"15","author":"T Wesemann","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"06","key":"ref23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jinf.2014.02.006","article-title":"Incidence, timing and risk factors associated with 1-year mortality after hospitalization for community-acquired pneumonia","volume":"68","author":"J Adamuz","year":"2014","journal-title":"J Infect"},{"issue":"06","key":"ref24","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.chest.2022.12.035","article-title":"Guideline-concordant antibiotic therapy for the hospital treatment of community-acquired pneumonia and 1-year all-cause and cardiovascular mortality in older adult patients surviving to discharge","volume":"163","author":"V F Corrales-Medina","year":"2023","journal-title":"Chest"},{"issue":"01","key":"ref25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1378\/chest.10-1054","article-title":"Only severely limited, premorbid functional status is associated with short- and long-term mortality in patients with pneumonia who are critically ill: a prospective observational study","volume":"139","author":"W I Sligl","year":"2011","journal-title":"Chest"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1086\/379712","article-title":"Assessment of mortality after long-term follow-up of patients with community-acquired pneumonia","volume":"37","author":"E M Mortensen","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/QCO.0b013e32835ebc6d","article-title":"Long-term prognosis in community-acquired pneumonia","volume":"26","author":"M I Restrepo","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"07","key":"ref28","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1399-6576.2011.02535.x","article-title":"Hospital and long-term outcomes of ICU-treated severe community- and hospital-acquired, and ventilator-associated pneumonia patients","volume":"55","author":"J Karhu","year":"2011","journal-title":"Acta Anaesthesiol Scand"},{"issue":"01","key":"ref30","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13054-020-03442-z","article-title":"Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs","volume":"25","author":"C Dupuis","year":"2021","journal-title":"Crit Care"},{"issue":"01","key":"ref31","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s13054-023-04466-x","article-title":"Impact of macrolide treatment on long-term mortality in patients admitted to the ICU due to CAP: a targeted maximum likelihood estimation and survival analysis","volume":"27","author":"L F Reyes","year":"2023","journal-title":"Crit Care"},{"issue":"03","key":"ref32","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.chest.2020.03.051","article-title":"The burden of community-acquired pneumonia requiring admission to ICU in the United States","volume":"158","author":"R Cavallazzi","year":"2020","journal-title":"Chest"},{"issue":"06","key":"ref33","first-page":"308","article-title":"Mid-regional proadrenomedullin: an early marker of response in critically ill patients with severe community-acquired pneumonia?","volume":"22","author":"J M Pereira","year":"2016","journal-title":"Rev Port Pneumol (2006)"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jcrc.2017.08.048","article-title":"Impact of antibiotic therapy in severe community-acquired pneumonia: data from the Infauci study","volume":"43","author":"J M Pereira","year":"2018","journal-title":"J Crit Care"},{"issue":"08","key":"ref35","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","article-title":"Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia","volume":"48","author":"G U Meduri","year":"2022","journal-title":"Intensive Care Med"},{"issue":"04","key":"ref36","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1532-5415.2007.01100.x","article-title":"Influence of comorbid conditions on long-term mortality after pneumonia in older people","volume":"55","author":"S Yende","year":"2007","journal-title":"J Am Geriatr Soc"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"e0148741","DOI":"10.1371\/journal.pone.0148741","article-title":"Risk factors for long-term mortality after hospitalization for community-acquired pneumonia: a 5-year prospective follow-up study","volume":"11","author":"J C Holter","year":"2016","journal-title":"PLoS One"},{"issue":"03","key":"ref38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/archinte.163.3.317","article-title":"Pneumonia: still the old man's friend?","volume":"163","author":"V Kaplan","year":"2003","journal-title":"Arch Intern Med"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/thoraxjnl-2014-206744","article-title":"Community-acquired pneumonia as medical emergency: predictors of early deterioration","volume":"70","author":"M Kolditz","year":"2015","journal-title":"Thorax"},{"issue":"01","key":"ref40","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1183\/09031936.00130909","article-title":"Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia","volume":"36","author":"S Aliberti","year":"2010","journal-title":"Eur Respir J"},{"issue":"05","key":"ref41","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","article-title":"Treatment of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies","volume":"158","author":"J A Ramirez","year":"2020","journal-title":"Chest"},{"issue":"03","key":"ref42","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1183\/20734735.0205-2019","article-title":"Hot topics and current controversies in community-acquired pneumonia","volume":"15","author":"D Severiche-Bueno","year":"2019","journal-title":"Breathe (Sheff)"},{"issue":"05","key":"ref43","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.resinv.2015.05.003","article-title":"Update on the combination effect of macrolide antibiotics in community-acquired pneumonia","volume":"53","author":"M Emmet O'Brien","year":"2015","journal-title":"Respir Investig"},{"issue":"05","key":"ref44","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4187\/respcare.05943","article-title":"Prophylactic antibiotic use in COPD and the potential anti-inflammatory activities of antibiotics","volume":"63","author":"A W Huckle","year":"2018","journal-title":"Respir Care"},{"issue":"04","key":"ref45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ejim.2013.12.001","article-title":"The management of community-acquired pneumonia in the elderly","volume":"25","author":"P Faverio","year":"2014","journal-title":"Eur J Intern Med"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1097\/CCM.0b013e3181eedaeb","article-title":"Age still matters: prognosticating short- and long-term mortality for critically ill patients with pneumonia","volume":"38","author":"W I Sligl","year":"2010","journal-title":"Crit Care Med"},{"issue":"02","key":"ref47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1378\/chest.09-2702","article-title":"Decrease in long-term survival for hospitalized patients with community-acquired pneumonia","volume":"138","author":"J Bordon","year":"2010","journal-title":"Chest"},{"issue":"02","key":"ref48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1086\/589246","article-title":"Acute myocardial infarction in hospitalized patients with community-acquired pneumonia","volume":"47","author":"J Ramirez","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"02","key":"ref49","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1086\/518849","article-title":"The association between pneumococcal pneumonia and acute cardiac events","volume":"45","author":"D M Musher","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"06","key":"ref50","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.111.040766","article-title":"Cardiac complications in patients with community-acquired pneumonia: incidence, timing, risk factors, and association with short-term mortality","volume":"125","author":"V F Corrales-Medina","year":"2012","journal-title":"Circulation"},{"issue":"12","key":"ref51","doi-asserted-by":"crossref","first-page":"e1125","DOI":"10.1016\/j.ijid.2013.07.005","article-title":"Risk factors for cardiovascular events in hospitalized patients with community-acquired pneumonia","volume":"17","author":"A T Griffin","year":"2013","journal-title":"Int J Infect Dis"},{"issue":"01","key":"ref52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jinf.2012.09.003","article-title":"Risk stratification and prognosis of acute cardiac events in hospitalized adults with community-acquired pneumonia","volume":"66","author":"D Viasus","year":"2013","journal-title":"J Infect"},{"issue":"03","key":"ref53","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/jama.2014.18229","article-title":"Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease","volume":"313","author":"V F Corrales-Medina","year":"2015","journal-title":"JAMA"},{"issue":"03","key":"ref54","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/QCO.0000000000000055","article-title":"Cardiac diseases complicating community-acquired pneumonia","volume":"27","author":"S Aliberti","year":"2014","journal-title":"Curr Opin Infect Dis"},{"issue":"11","key":"ref55","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1164\/rccm.200712-1777OC","article-title":"Inflammatory markers at hospital discharge predict subsequent mortality after pneumonia and sepsis","volume":"177","author":"S Yende","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"03","key":"ref56","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/hrt.78.3.273","article-title":"Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease","volume":"78","author":"M A Mendall","year":"1997","journal-title":"Heart"},{"issue":"03","key":"ref57","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1084\/jem.183.3.949","article-title":"Tumor necrosis factor alpha and interleukin 1beta are responsible for in vitro myocardial cell depression induced by human septic shock serum","volume":"183","author":"A Kumar","year":"1996","journal-title":"J Exp Med"},{"issue":"02","key":"ref58","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1473-3099(09)70331-7","article-title":"Role of acute infection in triggering acute coronary syndromes","volume":"10","author":"V F Corrales-Medina","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"ref59","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.3390\/microorganisms10112177","article-title":"Cardiovascular complications in community-acquired pneumonia","volume":"10","author":"A Desai","year":"2022","journal-title":"Microorganisms"},{"issue":"05","key":"ref60","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1164\/rccm.201701-0104OC","article-title":"Severe pneumococcal pneumonia causes acute cardiac toxicity and subsequent cardiac remodeling","volume":"196","author":"L F Reyes","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"18","key":"ref61","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1177\/2047487317724009","article-title":"Severe infections and subsequent delayed cardiovascular disease","volume":"24","author":"C Bergh","year":"2017","journal-title":"Eur J Prev Cardiol"},{"issue":"02","key":"ref62","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3390\/jcm9020414","article-title":"Cardiovascular events after community-acquired pneumonia: a global perspective with systematic review and meta-analysis of observational studies","volume":"9","author":"A Tralh\u00e3o","year":"2020","journal-title":"J Clin Med"},{"issue":"04","key":"ref63","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3233\/JAD-200303","article-title":"Common bacterial infections and risk of dementia or cognitive decline: a systematic review","volume":"76","author":"R Muzambi","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"01","key":"ref64","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1164\/ajrccm.160.1.9708059","article-title":"Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome","volume":"160","author":"R O Hopkins","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"02","key":"ref65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1164\/rccm.200903-0442OC","article-title":"Long-term cognitive and psychological outcomes in the awakening and breathing controlled trial","volume":"182","author":"J C Jackson","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"ref66","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis","volume":"304","author":"T J Iwashyna","year":"2010","journal-title":"JAMA"},{"issue":"14","key":"ref67","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1056\/NEJMoa1301372","article-title":"Long-term cognitive impairment after critical illness","volume":"369","author":"P P Pandharipande","year":"2013","journal-title":"N Engl J Med"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(09)61158-2","article-title":"Systemic infection and delirium: when cytokines and acetylcholine collide","volume":"375","author":"W A van Gool","year":"2010","journal-title":"Lancet"},{"key":"ref69","first-page":"756357","article-title":"A review: inflammatory process in Alzheimer's disease, role of cytokines","volume":"2012","author":"J M Rubio-Perez","year":"2012","journal-title":"ScientificWorldJournal"},{"issue":"03","key":"ref70","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"M D Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"03","key":"ref71","doi-asserted-by":"crossref","first-page":"00328","DOI":"10.1183\/23120541.00328-2022","article-title":"Incidence of cognitive impairment and dementia after hospitalisation for pneumonia: a UK population-based matched cohort study","volume":"9","author":"C V Chalitsios","year":"2023","journal-title":"ERJ Open Res"},{"issue":"04","key":"ref72","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s40520-014-0297-9","article-title":"Delirium symptoms during hospitalization predict long-term mortality in patients with severe pneumonia","volume":"27","author":"S Aliberti","year":"2015","journal-title":"Aging Clin Exp Res"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bbi.2022.04.002","article-title":"Bacterial pneumonia and subsequent dementia risk: a nationwide cohort study","volume":"103","author":"C S Chu","year":"2022","journal-title":"Brain Behav Immun"}],"container-title":["Seminars in Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1781426.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:58:00Z","timestamp":1730804280000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1781426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,23]]},"references-count":73,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,4,11]]},"published-print":{"date-parts":[[2024,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1781426","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["1069-3424","1098-9048"],"issn-type":[{"value":"1069-3424","type":"print"},{"value":"1098-9048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,23]]}}}